• Department of Hematology, General Hospital of Chengdu Military Region, Chengdu, Sichuan 610083, P. R. China;
SU Yi, Email: gangan2008@sina.com
Export PDF Favorites Scan Get Citation

目的  增加对慢性淋巴细胞白血病合并非霍奇金淋巴瘤临床病例的认识。 方法  通过报道2011年11月和2012年7月入住的2例确诊为慢性淋巴细胞白血病合并非霍奇金淋巴瘤患者的诊治过程,复习文献,讨论其发病机制、治疗及预后。 结果  该2例患者均予以化疗,其中1例浅表淋巴结明显缩小,骨髓涂片基本恢复正常,病情控制较好;另1例合并症多、病情恶化快、肿瘤化疗效果欠佳,最后因呼吸衰竭死亡。 结论  慢性淋巴细胞白血病合并非霍奇金淋巴瘤,治疗上应综合考虑患者年龄、ECOG评分、临床分期、预后指数等因素,原则上以治疗恶性程度更高的非霍奇金淋巴瘤为主,可根据慢性淋巴细胞白血病分期进行观察、随访或积极治疗。

Citation: WANG Yi,FAN Fangyi,SU Yi,SUN Haoping,LIU Yilan,QIU Ling,SHUAI Yanrong,HE Guangcui,FU Li,YI Hai.. Clinical Analysis of Chronic Lymphocytic Leukemia Complicated with Non-Hodgkin’s Lymphoma. West China Medical Journal, 2013, 28(6): 837-839. doi: 10.7507/1002-0179.20130263 Copy

  • Previous Article

    Effects of Oridonin on the Progress of Apoptosis in Acute Lymphoblastic Leukemia Molt-4 Cells and Its Mechanism
  • Next Article

    Intestinal Lesions as the Primary Clinical Manifestation of Adult-onset Systemic Epstein-Barr Virus Positive T-cell Lymphoproliferative Disease